Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A

[1]  Da-Wei Gong,et al.  Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications , 2006, PLoS medicine.

[2]  P. Ridker,et al.  Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms , 2005, Nature Reviews Drug Discovery.

[3]  George P Chrousos,et al.  Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  P. Svensson,et al.  A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  Chang Yeop Han,et al.  Thematic review series : The Immune System and Atherogenesis Lipoprotein-associated inflammatory proteins : markers or mediators of cardiovascular disease ? , 2005 .

[6]  M. Irwin,et al.  Inflammatory Markers and Sleep Disturbance in Major Depression , 2005, Psychosomatic medicine.

[7]  K. Clément,et al.  Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition , 2005, Diabetologia.

[8]  Peter Herscovitch,et al.  Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. , 2004, Archives of general psychiatry.

[9]  B. Murtagh,et al.  Inflammation and atherosclerosis in acute coronary syndromes. , 2004, The Journal of invasive cardiology.

[10]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[11]  A. Sherwood,et al.  Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment , 2004, Psychosomatic medicine.

[12]  D. Panagiotakos,et al.  Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. , 2004, European heart journal.

[13]  L. Wulsin.  Is Depression a Major Risk Factor for Coronary Disease? A Systematic Review of the Epidemiologic Evidence , 2004, Harvard review of psychiatry.

[14]  S. Reis,et al.  Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[15]  J. Plutzky.  Peroxisome proliferator-activated receptors as therapeutic targets in inflammation. , 2003, Journal of the American College of Cardiology.

[16]  M. Puato,et al.  C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? , 2003, Journal of hypertension.

[17]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[18]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[19]  R. Carney,et al.  Clinical depression and inflammatory risk markers for coronary heart disease. , 2002, The American journal of cardiology.

[20]  G. De Backer,et al.  Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. , 2002, Atherosclerosis.

[21]  S. Tam,et al.  ACUTE PHASE SERUM AMYLOID A, CHOLESTEROL METABOLISM, AND CARDIOVASCULAR DISEASE , 2002, Pediatric pathology & molecular medicine.

[22]  R. Tracy.  Is visceral adiposity the "enemy within"? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[23]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[24]  E. Antman,et al.  Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. , 2000, Journal of the American College of Cardiology.

[25]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[26]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[27]  F. Brambilla,et al.  Blood levels of cytokines in elderly patients with major depressive disorder , 1998, Acta psychiatrica Scandinavica.

[28]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[29]  J. Manson,et al.  Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. , 1997, Circulation.

[30]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[31]  W. Rathmann,et al.  Sex differences in the relation of body composition to markers of inflammation. , 2006, Atherosclerosis.

[32]  P. Ridker,et al.  C-reactive protein, inflammation, and coronary risk. , 2000, The Medical clinics of North America.

[33]  A. Porta,et al.  C-Reactive Protein , Serum Amyloid A Protein , and Coronary Events , 1999 .

[34]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.